Pediatrix Medical (MD) Shares Outstanding (Weighted Average) (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $80.9 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $80.9 million, down 4.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $80.9 million (down 4.21% YoY), and the FY2025 annual result was $84.4 million, up 1.33% from the prior year.
• Shares Outstanding (Weighted Average) fell to $80.9 million in Q1 2026 per MD's latest filing, from $84.4 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $85.4 million in Q1 2022 and troughed at $80.9 million in Q1 2026.
• A 5-year average of $83.3 million and a median of $83.3 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Weighted Average) climbed 1.9% in 2025, then retreated 4.21% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $83.5 million in 2022, then retreated by 1.52% to $82.2 million in 2023, then rose by 1.37% to $83.3 million in 2024, then climbed by 1.33% to $84.4 million in 2025, then dropped by 4.21% to $80.9 million in 2026.
• Business Quant data shows MD's Shares Outstanding (Weighted Average) at $80.9 million in Q1 2026, $84.4 million in Q4 2025, and $84.6 million in Q3 2025.